Published 20:21 IST, June 11th 2024
US FDA Advisory Committee Unanimously Backs Eli Lilly's Alzheimer's Drug
The Alzheimer's drug 'donanemab' by Eli Lily received approval from the US Food and Drug Administration's committee of independent advisors.
Representative Photo | Image:
Freepik
- Listen to this article
- 2 min read
Advertisement
20:21 IST, June 11th 2024